• letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Allogene Therapeutics Allogene to Initiate the ALPHA Study for ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma ALLO-647, Allogene’s Proprietary anti-CD52 Antibody, Will be Administered as Part of the Lymphodepletion Regimen Paris (France) and South San Francisco, Calif. – January 28, 2019 – Servier, an independent international pharmaceutical company and Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical- stage biotechnology company pioneering the ...
    The post Servier, in Collaboration with Allogene Therapeutics, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T) Therapy appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: massgeneral.org From: news-medical.net A Massachusetts General Hospital (MGH) research team has found that the overgrowth of connective called fibrosis may block the effectiveness of immunotherapies against metastatic breast cancer. Their report published in PNAS also finds that plerixafor, a drug approved to mobilize blood system stem cells in the treatment of lymphoma and multiple myeloma patients, can reduce fibrosis ...
    The post Fibrosis-targeting drugs may benefit patients with late-stage, metastatic breast cancer appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    At my recent annual appointment with my oncologist, we got into a discussion about patients posting reviews of their doctors on the Internet and how they affect the professional on so many levels. This oncologist has been on my medical team for 11 years, after I had to get a second opinion following my first cancer diagnosis. His skills, concern ...
    The post Cancer: How Do You Choose the Right Doctor for You appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Lisa Chamoff From: dotmed.com Researchers at Washington University in St. Louis predict a new breast imaging modality that combines ultrasound and near-infrared imaging, or diffuse light tomography, can reduce unnecessary biopsies by up to 45 percent. The team — Quing Zhu, professor of biomedical engineering at the Washington University in St. Louis School of Engineering & Applied Science and ...
    The post New breast imagine modality may reduce unnecessary biopsies by up to 45 percent appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Henry Ford Health System From: newswise.com Breast cancer patient Laura Carey returned to work one week after beginning chemotherapy, but without a demoralizing side-effect indicative of this type of cancer treatment – hair loss. Carey is among the first breast cancer patients at the Henry Ford Cancer Institute to successfully prevent and reduce hair loss during chemotherapy by using ...
    The post Innovative Ice-Free Scalp Cooling During Chemotherapy Prevents, Reduces Hair Loss for Breast Cancer Patients appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: OncoQuest, Inc. From: prnewswire.com OncoQuest Inc., a privately held, cancer immunotherapy company, has retained the services of IQVIA, a company formed through the merger of IMS Health and Quintiles, to manage OncoQuest’s planned Phase 3 clinical study in frontline ovarian cancer with the company’s lead product candidate, oregovomab, an anti-CA-125 antibody. OncoQuest will collaborate with IQVIA, a leading global ...
    The post OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian Cancer appeared first on Let Life Happen.